Ablation of Inappropriate Sinus Tachycardia
... sant agents. Frankel et al. (18) described a history of ...
... sant agents. Frankel et al. (18) described a history of ...
Seborrheic dermatitis: Etiology, risk factors, and treatments: Facts and controversies ⁎
... the skin of lipid-rich anatomic locations, such as the face, scalp, and trunk,40 on the presence of Malassezia in affected SD skin, and on the therapeutic response seen to antifungal agents.11 Improvement in SD is accompanied by reduction in the yeast on the scalp, whereas recolonization leads to di ...
... the skin of lipid-rich anatomic locations, such as the face, scalp, and trunk,40 on the presence of Malassezia in affected SD skin, and on the therapeutic response seen to antifungal agents.11 Improvement in SD is accompanied by reduction in the yeast on the scalp, whereas recolonization leads to di ...
Prevention of Infections During Primary
... Granulocyte colony-stimulating factor (G-CSF) efficacy was demonstrated in a randomized controlled crossover trial [14]. Data on the long-term efficacy of G-CSF are scarce. Prolonged use increases the risk of myelodysplasia and/or acute leukemia, especially during prolonged exposure and at high doses. ...
... Granulocyte colony-stimulating factor (G-CSF) efficacy was demonstrated in a randomized controlled crossover trial [14]. Data on the long-term efficacy of G-CSF are scarce. Prolonged use increases the risk of myelodysplasia and/or acute leukemia, especially during prolonged exposure and at high doses. ...
data sheet
... When medically appropriate, gradual discontinuation of the previous treatment while RISPERDAL therapy is initiated is recommended. Also if medically appropriate, when switching patients from depot antipsychotics, initiate RISPERDAL therapy in place of the next scheduled injection. The need for conti ...
... When medically appropriate, gradual discontinuation of the previous treatment while RISPERDAL therapy is initiated is recommended. Also if medically appropriate, when switching patients from depot antipsychotics, initiate RISPERDAL therapy in place of the next scheduled injection. The need for conti ...
Neuroleptic Malignant Syndrome
... cause serotonin syndrome, which most often presents as an agitated delirium but resembles NMS in severe cases. It is important to differentiate between serotonin syndrome and NMS not only because the treatment approaches for the two conditions may differ but also because the diagnosis will affect ho ...
... cause serotonin syndrome, which most often presents as an agitated delirium but resembles NMS in severe cases. It is important to differentiate between serotonin syndrome and NMS not only because the treatment approaches for the two conditions may differ but also because the diagnosis will affect ho ...
Refractory Edema with Congestive Heart Failure Stepwise
... 2010 Heart Failure Society of America (HFSA) guidelines on acute decompensated HF (ADHF) recommend a sodium intake of less than 2 g/day. They even recommend greater sodium restriction ...
... 2010 Heart Failure Society of America (HFSA) guidelines on acute decompensated HF (ADHF) recommend a sodium intake of less than 2 g/day. They even recommend greater sodium restriction ...
... Assuming that at least a doubling of the anti-B. burgdorferi seroprevalence in a sarcoidosis population is of immunopathogenetic relevance, the sample size of our study and control populations were large enough to ascertain such a difference, with a probability of error <0.05. The fact that a signif ...
Gastrointestinal tract disorders
... About GI tract disorders Around 2–4 in 1,000 people in Northern Europe have ulcerative colitis or Crohn’s disease (Rubin 2000). Both are chronic, relapsing, inflammatory disorders of the gastrointestinal tract with several shared clinical features, but with largely distinct risk factors, genetic, im ...
... About GI tract disorders Around 2–4 in 1,000 people in Northern Europe have ulcerative colitis or Crohn’s disease (Rubin 2000). Both are chronic, relapsing, inflammatory disorders of the gastrointestinal tract with several shared clinical features, but with largely distinct risk factors, genetic, im ...
Minimally Invasive Treatment Options for Uterine Fibroids
... UAE for 5 years. At the end of 5 years, 73% reported continued symptom relief, 18% had undergone hysterectomy or myomectomy, and 2% had a repeat UAE. Long-term failure was greatest for women with larger baseline fibroid volumes and those not improved at 1 year [15]. Patients often report some degree ...
... UAE for 5 years. At the end of 5 years, 73% reported continued symptom relief, 18% had undergone hysterectomy or myomectomy, and 2% had a repeat UAE. Long-term failure was greatest for women with larger baseline fibroid volumes and those not improved at 1 year [15]. Patients often report some degree ...
Prosthetic joint infections of the hip and knee : treatment and
... The main data consist of 197 patients with PJI treated in Oulu University Hospital, Finland, between February 2001 and August 2009. Patients were identified retrospectively using the hospital’s patient databases. The study shows that, if antibiotic treatments for PJI are completed as planned, then D ...
... The main data consist of 197 patients with PJI treated in Oulu University Hospital, Finland, between February 2001 and August 2009. Patients were identified retrospectively using the hospital’s patient databases. The study shows that, if antibiotic treatments for PJI are completed as planned, then D ...
Chiropractic and Naturopathic Medicine for the
... regarding efficacy, safety, adverse effects, and cost-effectiveness. The scientific rationale and clinical basis for the nutritional, non-pharmacologic treatment of many common painful inflammatory disorders is well established in the peer-reviewed biomedical research. Many natural treatments (ie, s ...
... regarding efficacy, safety, adverse effects, and cost-effectiveness. The scientific rationale and clinical basis for the nutritional, non-pharmacologic treatment of many common painful inflammatory disorders is well established in the peer-reviewed biomedical research. Many natural treatments (ie, s ...
Gout in Indian Scenario - The Association of Physicians of India
... Relief of pain and inflammation is the primary aim of treatment in acute gout and this is achieved by:7 • Nonsteroidal anti-inflammatory drugs: Drugs like coxibs, naproxen, diclofenac, ibuprofen, piroxicam or indomethacin may be used. A note of caution is given for patients with peptic ulcer or r ...
... Relief of pain and inflammation is the primary aim of treatment in acute gout and this is achieved by:7 • Nonsteroidal anti-inflammatory drugs: Drugs like coxibs, naproxen, diclofenac, ibuprofen, piroxicam or indomethacin may be used. A note of caution is given for patients with peptic ulcer or r ...
Prehospital Thrombolysis: It`s All About Time
... 8.6±5.5; P<0.01) than patients receiving treatment between 1.5 and 4 hours from the onset of pain. Patients in the prehospital arm of the study also had better-preserved left ventricular function than patients treated in the hospital. The study concluded that thrombolytic therapy with streptokinase ...
... 8.6±5.5; P<0.01) than patients receiving treatment between 1.5 and 4 hours from the onset of pain. Patients in the prehospital arm of the study also had better-preserved left ventricular function than patients treated in the hospital. The study concluded that thrombolytic therapy with streptokinase ...
Final Project Version 1
... after exposure to Blastomyces dermatitidis vary greatly. Symptoms to different body parts include: cutaneous, bone, central nervous system, and other sites of infection. According to the CDC (2014), only 50% of the people exposed will actually have symptoms. Some symptoms are very similar to flu lik ...
... after exposure to Blastomyces dermatitidis vary greatly. Symptoms to different body parts include: cutaneous, bone, central nervous system, and other sites of infection. According to the CDC (2014), only 50% of the people exposed will actually have symptoms. Some symptoms are very similar to flu lik ...
Oral Appliance Treatment for Obstructive Sleep Apnea: An Update
... Sleepiness Score (ESS), improves with OAm compared to inactive appliances in the majority of studies,14-20 although a placebo effect on ESS has been reported.16,18 Objectively measured sleepiness by the multiple sleep latency test (MSLT) was improved only with active OAm.16 Three placebo-controlled ...
... Sleepiness Score (ESS), improves with OAm compared to inactive appliances in the majority of studies,14-20 although a placebo effect on ESS has been reported.16,18 Objectively measured sleepiness by the multiple sleep latency test (MSLT) was improved only with active OAm.16 Three placebo-controlled ...
a potential late and under recognized consequence of rugby
... The association between exposure to head injury and increased risk of neurodegenerative disease, specifically chronic traumatic encephalopathy (CTE), is widely recognized. Historically, this was largely considered a phenomenon restricted to boxers, with more recent case series identifying further ‘h ...
... The association between exposure to head injury and increased risk of neurodegenerative disease, specifically chronic traumatic encephalopathy (CTE), is widely recognized. Historically, this was largely considered a phenomenon restricted to boxers, with more recent case series identifying further ‘h ...
Combined pulmonary fibrosis and emphysema in patients exposed to agrochemical compounds CORRESPONDENCE
... factor, with tobacco exposure playing a central role. Here, we report our clinical experience of the same syndrome in order to emphasise the possible role of environmental exposure in the pathogenesis of the disease. Over the last 2 yrs, 41 patients with pulmonary fibrosis were investigated in our t ...
... factor, with tobacco exposure playing a central role. Here, we report our clinical experience of the same syndrome in order to emphasise the possible role of environmental exposure in the pathogenesis of the disease. Over the last 2 yrs, 41 patients with pulmonary fibrosis were investigated in our t ...
Echinacea
... clinical trial was held. • Involved 124 participants split into 2 groups. • One group received 100 mg of Echinacea purpurea and the other group received a placebo. • Both groups received doses 3 times a day until their cold was gone or until the end of 14 days. (1) ...
... clinical trial was held. • Involved 124 participants split into 2 groups. • One group received 100 mg of Echinacea purpurea and the other group received a placebo. • Both groups received doses 3 times a day until their cold was gone or until the end of 14 days. (1) ...
quality eye care standards and managed care for
... • Cell mediated immune response to viral antigens in stroma or ...
... • Cell mediated immune response to viral antigens in stroma or ...
INTRON® A (Interferon alfa-2b)
... and podophyllin was shown to be significantly more effective than podophyllin alone, as determined by the number of patients whose lesions cleared. This significant difference in response was evident after the second treatment (Week 3) and continued through 8 weeks post-treatment. At the time of the ...
... and podophyllin was shown to be significantly more effective than podophyllin alone, as determined by the number of patients whose lesions cleared. This significant difference in response was evident after the second treatment (Week 3) and continued through 8 weeks post-treatment. At the time of the ...
EULAR recommendations for the management of familial
... with active disease to determine the necessary colchicine dose. Disease severity and patients’ tolerance of FMF attacks should also be taken into account in establishing a tailored colchicine dose. 6. Compliant patients not responding to the maximum tolerated dose of colchicine can be considered non ...
... with active disease to determine the necessary colchicine dose. Disease severity and patients’ tolerance of FMF attacks should also be taken into account in establishing a tailored colchicine dose. 6. Compliant patients not responding to the maximum tolerated dose of colchicine can be considered non ...
Acute Symptoms of Drug Hypersensitivity
... Drug hypersensitivity reactions (HSRs) are the adverse effects of drugs which, when taken at doses generally tolerated by normal subjects, clinically resemble allergy.1 Although they occur in a small percentage of patients (about one-third of all adverse drug reactions, which affect 10% to 20% of th ...
... Drug hypersensitivity reactions (HSRs) are the adverse effects of drugs which, when taken at doses generally tolerated by normal subjects, clinically resemble allergy.1 Although they occur in a small percentage of patients (about one-third of all adverse drug reactions, which affect 10% to 20% of th ...
Management of multiple sclerosis
Several therapies for multiple sclerosis (MS) exist, although there is no known cure. Multiple sclerosis is a chronic inflammatory demyelinating disease that affects the central nervous system (CNS).The most common initial course of the disease is the relapsing-remitting subtype, which is characterized by unpredictable attacks (relapses) followed by periods of relative remission with no new signs of disease activity. After some years, many of the people who have this subtype begin to experience neurologic decline without acute relapses. When this happens it is called secondary progressive multiple sclerosis. Other, less common, courses of the disease are the primary progressive (decline from the beginning without attacks) and the progressive-relapsing (steady neurologic decline and superimposed attacks). Different therapies are used for patients experiencing acute attacks, for patients who have the relapsing-remitting subtype, for patients who have the progressive subtypes, for patients without a diagnosis of MS who have a demyelinating event, and for managing the various consequences of MS.The primary aims of therapy are returning function after an attack, preventing new attacks, and preventing disability. As with any medical treatment, medications used in the management of MS may have several adverse effects, and many possible therapies are still under investigation. At the same time different alternative treatments are pursued by many patients, despite the paucity of supporting, comparable, replicated scientific study.This article focuses on therapies for standard MS; borderline forms of MS have particular treatments that are excluded.